RNS Number : 6442X
UK Oil & Gas PLC
13 August 2018
 

UK Oil & Gas PLC

("UKOG" or the "Company")

Exercise of Warrants

UKOG announces that it has received notice of the exercise of warrants to subscribe for a total of 14 million new ordinary shares in the Company (the "New Ordinary Shares"). The Company has received £126,000 in respect of this exercise.

Application has been made for these New Ordinary Shares to be admitted to trading on AIM and it is anticipated that trading in such shares will commence on or around 17 August 2018.

 

Following Admission, the Company's enlarged issued share capital will comprise  5,221,240,526  ordinary shares. The Company does not hold any shares in treasury. This figure of 5,221,240,526 ordinary shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.

For further information, please contact:

 

UK Oil & Gas PLC

Stephen Sanderson / Kiran Morzaria                                     Tel: 01483 243450 

 

WH Ireland (Nominated Adviser and Broker)

James Joyce / James Sinclair-Ford                                          Tel: 020 7220 1666

 

Cenkos Securities PLC (Joint Broker)

Joe Nally / Neil McDonald                                                         Tel: 0207 397 8919

 

Public Relations

Brian Alexander / David Bick                                                    Tel: 01483 243450

 

The information contained within this announcement is deemed by the Company to constitute inside information under the Market Abuse Regulation (EU) No. 596/2014.

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IOEBDGDIIUBBGIX